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The current scientific literature reports on the incidence of hearing impairments due to HIV/AIDS, 
and the hearing changes can occur due to damage to the outer, middle or inner ear. Thus, it is 
important to study how these changes occur, the hearing loss and their associations with the 
HIV/AIDS infection.
Objective: To identify the factors related to hearing loss in people with HIV/AIDS in the global 
scientific literature.
Method: Study carried out an Integrative Review of the Literature. The key words used were: hearing 
loss, hearing disorders and deafness, separately associated to the keyword HIV on PUBMED, ScIELO, 
LILACS and ISI databases. We used complete original papers, of free access, in English, Spanish, 
French and Portuguese. Thirteen quantitative studies from 1994-2010 were selected.
Conclusion: We did not find any strong direct association between anti-retroviral therapy and hearing 
loss; however, there are indications of hearing loss in the population studied, and their associations 
and causes need to be better investigated.
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INTRODUCTION
In recent years, there has been promising de-
velopments in world initiatives to approach the AIDS 
epidemics, including a greater access to efficient tre-
atment and prevention programs1. Notwithstanding, 
the AIDS issue remains as one of the most important 
health care challenges for world public health.
Considering such challenges, treatment with 
antiretroviral (ARV) medication is one of our greatest 
allies in controlling disease progression. These drugs 
started to be used worldwide by means of a mono-
therapy with Zidovudine, in 1987, until we reached 
a point of having a combination of drugs, known as 
TARV2,3. In Brazil, TARV started in 1991, and five years 
later a law was approved, making it mandatory the 
free distribution of the drug4.
Treatment with ARV medication has been the 
most important factor to control AIDS evolution, its 
chronicity and to guarantee the survival of those in-
fected.
Considering HIV’s specificity, which affects the 
immune system, favoring the incidence of diseases 
which prey on low immunity5, the TARV used to pre-
vent these diseases causes intense or undesirable side 
effects, which is a problem for treatment. Although the 
progress in drug therapy has brought about a reduc-
tion in mortality and morbidity, there are a number 
of repercussions arising from it, such as the array of 
adverse effects associated with the ARVs, which cau-
ses a negative impact on the quality of life of those 
individuals who depend on the treatment6. Thus the 
need for healthcare professionals to pay the proper 
attention to these individuals, providing information 
about the potential side effects of each medication 
prescribed and the implementation of maneuvers 
in order to reduce the incidence of undesirable side 
effects. We also stress the importance of instructions 
concerning the concurrent use of other medications 
which may increase undesirable side effects7.
Studies have proven that some ARV medications 
may have potential ototoxic effects and cause hearing 
loss, and they point to a possible association with 
hearing loss in the central hearing system7 caused by 
the direct action of the virus, which in many cases is 
shown by otoneurological signs and symptoms pre-
sented by or reported by the patients, such as hearing 
loss, tinnitus and dizziness8,9.
The hearing loss may be described as any re-
duction in hearing and/or in the person’s capacity to 
detect speech or ambient sounds, regardless of cause, 
type of degree. This may happen at different moments 
in life, during gestation or delivery, in childhood, 
adult life or old age10. It may also be classified by type 
(conductive, sensorineural and/or mixed)11, as well as 
in relation to the degree (mild, moderate, moderately 
severe, severe and profound)12.
Knowledge about the hearing changes and 
early diagnosis concerning hearing loss helps in the 
prognosis, reduces the damages caused by disease 
development, reduces sensorial deprivation, improves 
inclusion in society and, it also contributes to impro-
ving quality of life. Thus, it is relevant to investigate 
how such hearing loss happened and its relationship 
with the HIV infection/AIDS in affected people.
Therefore, we ask: how have the HIV-associated 
hearing changes been approached in the scientific li-
terature? Which factors are associated with the hearing 
loss in patients with HIV/AIDS?
It is worth stressing that there is a need for a 
hearing health policy encompassing the particulari-
ties associated with prevention, early diagnosis and 
treatment of hearing disorders in the Brazilian public 
healthcare system.
In pursuing these answers, our study aimed at 
identifying the factors associated with hearing loss in 
people with HIV/AIDS in the literature.
METHOD
This is an Integrative Literature Review, which 
enables the abstracting of previous studies and esta-
blishing conclusions based on the critical review of the 
studies outlines, enabling one to summarize the evi-
dence available about the theme being investigated13.
The stages followed in order to operate this 
review involved: problem identification, creation of 
a research protocol, defining the information to be 
extracted from the papers selected, selection of papers, 
analysis, presentation and discussion of results13,14.
The papers were searched in four virtual da-
tabases, namely: ISI Web of Knowledge (Institute for 
Scientific Information), PUBMED/MEDLINE (Medical 
Literature Analysis), LILACS (Literatura Latino-Ameri-
cana em Ciências de Saúde - Health Sciences Latin 
American Literature) and SCIELO (Scientific Electronic 
Library Online), using the following keywords listed 
in the Health Sciences Keywords: hearing loss, hearing 
disorders and deafness, individually associated to the 
HIV keyword.
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The inclusion criteria were: original papers, 
open access papers, papers published in Portuguese, 
Spanish, English and French, without time constraints. 
The exclusion criteria were: repetitive papers, reviews, 
meeting proceedings, opinion papers, editorials, the-
ses, dissertations, epidemiological bulletins, papers 
which do not directly approach the theme of this 
study.
We found a total of 41 publications. After re-
ading the title and summary, we took off repeated 
papers and those which did not meet the inclusion 
criteria. There were 22 papers left for complete text 
analysis, and of these we took nine papers off be-
cause they were not associated with the theme being 
studied. The sample was made up of 13 scientific 
papers, as per shown by Figure 1 below.
In order to extract the data from the selected 
studies, we created a table with columns, bearing the 
following information: year of publication, authors, 
title, journal, country, type of study, study design, set-
tings, target population, hearing loss-HIV association.
The data was grouped according to the simila-
rities and differences, making up a finding which was 
interpreted and supported by other pertaining papers. 
All the studies selected are listed on Chart 1 and have 
references in this text. Figure 1. Summary of the process used to select the papers used in 
the integrative review of the literature.
Chart 1. Selected papers on hearing loss and associated factors in people with HIV/AIDS, according to author, year and country 
of publication, title, study type, study goals, and factors associated with hearing loss.
Author Country/year Title Study type Objective Associated factors
Vieira ABC, 
Greco DB, Teófilo MMM, 
Gonçalves DU.15
Brazil/2008
Otoneurological manifestations 
associated with the 
antiretroviral therapy
Case-control study
Assess a possible cor-
relation between ototo-
xicity and antiretroviral 
therapy
Ototoxicity 
Virus action
Schouten JT, 
Lockhart DW, 
Rees TS, Collier AC, 
Marra CM.9
USA/2006
A prospective study of hearing 
changes after beginning 
Zidovudine or Didanosine in 
HIV-1 treatment-naïve people
Prospective study
To assess the effects of 
Zidovudine and Dida-
nosine causing hearing 
loss
Ototoxicity 
Virus action
Matas CG, 
Marcon BA,Silva SM, 
Gonçalves IC.16
Brazil/2010
Hearing assessment in the 
Acquired Immunodeficiency 
syndrome
Case-control study
Characterize the audio-
logical manifestations 
in HIV/AIDS adults and 
compare the results 
from individuals who 
were exposed to those 
who were not exposed 
to antiretroviral treat-
ment
Ototoxicity 
Virus action
Palacios GC, 
Montalvo MS, Freire MI, 
Leon E, Alvarez MT, 
Solorzano F.17
México/2008
Audiological and vestibular 
findings in a sample of Human 
Immunodeficiency Virus type-1-
-infected Mexican children 
under Highly Active Antiretrovi-
ral Therapy
Case-control study
Assess audiological and 
vestibular disorders in 
children with HIV who 
received highly active 
antiretroviral therapy
Opportunistic 
diseases 
Ototoxicity
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Meynardi JL, 
Amrani ML, Meyohas 
MC, Fligny I, Gozlan 
J, Rozenbaum W, 
Roullet E, Frottier J.18
France/1997
Two cases of cytomegalovirus 
infection revealed by hearing 
loss in HIV-infected patients
Case study
To report two cases in 
which the cytomegalo-
virus infection was reve-
aled by the involvement 
of the 8th cranial nerves
Opportunistic 
diseases
Colugnati FB, 
Staras SAS, Dollard SC, 
Cannon MJ.19
USA/2007
Incidence of cytomegalovirus 
infection among the general 
population and pregnant 
women in the United States
Cohort study
Obtain estimates of 
infection forces, basic 
reproduction rates, and 
the mean age of CMV 
infection
Opportunistic 
diseases
Chandrasejhar SS, 
Sujana S, Connelly 
PE, Brahrnbhatt SS, 
Shah CS, Kloser PC, 
Baredes S.20
USA/2000
Otological and Audiological 
Evaluation of Human 
Immunodeficiency Virus-
Infected Patients
Case study
Quantify the incidence 
of ear disease in HIV-
-infected patients
Ototoxicity
Khanna N, Nüesch R, 
Buitrago-Tellez C, 
Battegay M, 
Hirsch HH.21
Switzerland/ 
2006
Hearing Loss after Disconti-
nuing Secondary Prophylaxis 
for Cryptococcal Meningitis: 
Relapse or Immune Reconsti-
tution?
Case study
Report on the case of a 
26-year-old HIV-infected 
men with right-side he-
aring loss two months 
after interruption of the 
secondary prophylaxis 
because of cryptococ-
cosis and meningitis.
Opportunistic 
diseases and 
virus action
Molyneux EM, Tembo 
M, Kayira K, Bwanaisa 
L, Mweneychanya J, 
Njobvu A, Forsyth H, 
Rogerson SR, Walsh 
AL, Molyneux ME.22
Malawi/2003
The effect of HIV infection on 
pediatric bacterial meningitis in 
Blantyre, Malawi
Case-control study
Compare the presenta-
tion, progress and results 
from acute bacterial 
meningitis in HIV-positive 
and negative children
Opportunistic di-
seases and virus 
action
Klemm E, Wollina U.23 Germany/ 2004 Otosyphilis: report on six cases
Cross-sectional/
longitudinal cohort 
study
Investigate the fre-
quency, clinical presen-
tation and results from 
otosyphilis
Opportunistic 
diseases and 
virus action
Soumare M, Seydi 
M, Ndour CT, Fall N, 
Dieng Y, Sow AI, Diop 
BM.24
Sene-
gal/2005
Epidemiological, clinical, 
etiological features of 
neuromeningeal diseases at 
the Fann Hospital Infectious 
Diseases Clinic, Dakar
Retrospective 
study
Determine the prevalen-
ce of cerebromeningeal 
diseases, and describe 
epidemiological data, 
clinical and etiological 
characteristics
Opportunistic 
diseases
Shahab I, Osbone 
BM, Butler JJ.25
USA/1994
Nasopharyngeal Lymphoid 
Tissue Masses in Patients with 
Human Immunodeficiency 
Virus
Histology findings 
and clinical corre-
lation
Check for a correlation 
between HIV-1 and 
nasopharyngeal lym-
phoma
Opportunistic 
diseases
Wenzel GI, Götz F, 
Lenarz T, Stöver T.26
Germany/ 
2008
HIV-associated cerebral 
lymphocyte infltration 
mimicking vestibular 
schwannoma
Case study
Report the first case 
of HIV associated with 
primary cerebral lym-
phocytes.
Ototoxicity
Continued Chart 1.
RESULTS
To analyze and discuss the occurrence of hea-
ring disorders in HIV/AIDS patients and its associated 
factors in the selected papers, they were organized 
in topics. Since it was not possible to group the stu-
dies by methodological similarity, we chose to group 
the findings by adherence to theme, namely: “Virus 
action9,15,16,21,22 and ototoxicity”9,15-17,20,26; and “Opportu-
nistic diseases and hearing loss”17-19,21,22,24,25.
Virus action and ototoxicity
In 1995, authors had already found a high 
incidence of audiological changes in HIV-positive 
patients27. Notwithstanding, they emphasize the di-
fficulties in stating whether these findings would be 
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due to the direct action of the virus on the hearing 
pathways or a consequence of the ototoxicity induced 
by the medication used by these patients.
In a recent study involving adult patients treated 
and not treated by ARV therapy, the audiological ma-
nifestations (hearing loss, tinnitus and dizziness) were 
more frequent than the vestibular changes in patients 
treated with ARV. There were thirty-nine treatment 
regimens utilized in the group of treated patients, 
and five of those treatment regimens were associated 
with otoneurological signs (Didanosine-Lamivudine-
-Lopinavir/r; Zidovudine-Lamivudine-Efavirenz; Zi-
dovudine-Lamivudine-Nevirapine; Stavudine-Lamivu-
dine-Lopinavir/r; Zidovudine-Didanosine-Nelfinavir), 
and there were no significant correlation between the 
ototoxicity and the ARV treatment15. Moreover, in 33 
individuals using antiretroviral with peripheral T CD4+ 
cells below 200 cel./ml, we also did not correlate 
hearing loss to using AZT and ddI. Thus, the initial 
hearing involvement in adults may be associated with 
the direct action of the virus on the central auditory 
system9.
However, adult HIV-positive individuals be-
tween 18 and 58 years of age, exposed to ARV treat-
ment, had changes suggestive of peripheral auditory 
pathway involvement and also had high frequency 
hearing thresholds compromised16 when compared 
to the untreated group.
HIV/AIDS patients may have changes in their 
conventional audiological assessment, high-frequency 
audiometry, otoacoustic emissions, otoacoustic emis-
sion suppression and in auditory evoked potentials, 
suggesting involvement in the periphery auditory 
pathway as well as in the central auditory pathway7,16.
High-frequency audiometry assesses hearing in 
the range above 8,000 Hz - between 9,000 and 20,000 
Hz - and does not have standardized results, such as 
in a conventional audiometry - between 250 and 8,000 
Hz. Nevertheless, people with HIV/AIDS are the first 
to be affected with some ear disorders, showing an 
important element used in early diagnosis28.
High-frequency audiometry is very useful to 
follow up patients exposed to intense noise: those 
who use ototoxic medication; as well as those expo-
sed to degenerative etiological agents; nonetheless, 
some factors prevent this test to be part of the clinical 
routine, they are: we still lack a normality standard 
to test these frequencies, specificity in the equipment 
calibration patterns and the methodology employed, 
which may impact the results obtained29.
We stress the study carried out with 23 children 
(ranging between 5 months and 16 years of age) 
diagnosed with HIV/AIDS, receiving highly active 
ARV therapy. Tonal audiometry was carried out in 
12 children with more than 4 years of age, and 33% 
had hearing loss, two were of conduction type. The 
brainstem responses were measured in all 23 children, 
suggesting a conductive hearing loss in six and sen-
sorineural in two. Concerning the brainstem auditory 
responses, they had changes at different levels of the 
auditory pathways19, showing that children with HIV 
and using ARV therapy are prone to having auditory 
changes, just as well as adults are.
Thus, there are peripheral auditory pathway 
changes affecting people with HIV/AIDS associated 
with ototoxicity and to the high viral load or virus 
action. One may suppose that such fact is due to the 
morphological arrangement of the nervous fibers, sin-
ce they have characteristics of the hair cells and/or of 
neurons, in responding in a specialized way to certain 
frequencies, which is called tonotopy. In tonotopy, 
the nervous fibers coming from the cochlear apex and 
forming the central region of the cochlear nerve are 
responsible for the transmission of low frequencies, 
while those fibers coming from the base and make 
up the periphery region of the nerve, are responsible 
for transmitting high frequencies, showing that, in 
current times it is not possible to be clear about the 
agent causing hearing loss in these people30.
Opportunistic diseases and hearing loss
Concerning opportunistic diseases associated 
with hearing loss, we have the prevalence of central 
nervous system infections by cytomegalovirus (CMV), 
which must be considered as a cause for hearing loss 
in HIV-infected patients18.
CMV is a broadly distributed infectious agent 
in the general population, belonging to the herpes 
virus family, and it is a frequent cause of infections 
in human beings. This virus has periods of activation 
and latency, and once the person is infected, the virus 
remains indefinitely in the host’s body, and it can be 
reactivated at any time, especially in the presence of 
immunosuppression agents31.
CMV incidence in the United States population 
is 1.6 infections for every 100 persons per year - and 
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these are individuals with low family income. There 
are about 27,000 new CMV infections among serum-
-negative pregnant women every year19. In Brazil, 
serum-prevalence studies in the adult population have 
shown approximately 90% of positivity in the city of 
São Paulo32, as well as in Santa Catarina state33.
Upon studying 50 cases of patients infected 
with HIV aiming at characterizing the occurrence of 
ear diseases, we used a questionnaire, ear exam, au-
diological assessment and reviewing hospital charts. 
Among the otological manifestations we had: ear 
fullness (34%), tinnitus (26%), hearing loss (29%), 
otalgia (23%) and otorrhea (5%). Otitis media was also 
a frequent finding in these patients, and the sensori-
neural hearing loss was more severe in HIV patients, 
but it was not associated with the routine medication 
used to treat HIV/AIDS. The authors concluded that 
auditory disease affects up to 33% of HIV-infected 
patients, and sensorineural hearing loss is more severe 
in this specific group20.
We know that otitis may cause temporary peri-
pheral hearing loss, and it must be diagnosed as soon 
as possible in order to install proper medical treatment. 
According to the National Institute of Health of the 
USA, there are about 75% of adults with AIDS with 
some kind of hearing disorder arising from opportu-
nistic infections, its treatment and ototoxic effect34.
There is a case report of a male patient infected 
with HIV who had hearing loss on the right side two 
months after secondary prophylaxis for cryptococcuc 
meningitis. The authors associate the unilateral hearing 
loss of adult patients with cryptococcus meningitis and 
the treatment of HIV-associated infections21.
HIV-infected children were assessed in order to 
measure their audiological skills and vestibular disor-
ders, considering that they were under highly active 
antiretroviral treatment. We included 23 patients with 
mean age of 4.5 years; audiometry was carried out 
in 12 children with more than 4 years of age. Four 
children had sensorineural hearing loss and two of 
them had conduction-type hearing loss. Brainstem 
responses were measured in all the patients, sugges-
ting conductive-type hearing loss in six children and 
sensorineural hearing loss in two. The ones diagnosed 
with conductive hearing loss had a past of acute or 
chronic otitis media. These results suggest that chil-
dren with HIV-1 must be audiologically assessed as 
soon as possible in order to reduce its impact on their 
psychosocial development17. We have also noticed 
that HIV+ children develop bacterial meningitis, have 
a high mortality rate, and are more prone to recurrent 
diseases22.
One epidemiological study carried out in or-
der to study the frequency and clinical presentation 
of otosyphilis results in developed countries confir-
med that it still is a complication of syphilis in these 
countries. Thus, we can state that this disease is a 
known cause of sensorineural hearing loss and has 
a higher prevalence among HIV patients. The otolo-
gical involvement by Treponema pallidum happens 
in the tertiary syphilis. Initial symptoms may include 
uni or bilateral sensorineural hearing loss, usually of 
rapid progression and, often times sudden. Tinnitus, 
ear pressure and labyrinthine symptoms may also be 
present. The audiometric curve usually shows a drop 
in the low frequencies, suggesting endolymphatic 
hydrops3.
Cerebromeningeal diseases may be associated 
with hearing loss. In a retrospective study carried out 
in Senegal, with the aim of establishing the prevalen-
ce of cerebromeningeal involvement in hospitalized 
patients and describe epidemiology, clinical signs 
and symptoms and disease etiology, there were 470 
cases identified - 89 children and adults had HIV and 
numerous opportunistic disorders, such as meningeal 
syndrome, coma, seizure, focal neurological failure, 
cranial nerve dysfunction, cerebral malaria, purulent 
meningitis, cryptococcal meningitis, tuberculous 
meningitis, intracranial abscess, toxoplasmosis, ce-
rebromeningeal hemorrhage. Of the 89 investigated, 
22 survived and among these there were five with 
hearing loss. The study concluded that the labs must 
have greater technical capacity to diagnose the op-
portunistic infections presented by these patients, as 
well as involve the many experts to manage cerebro-
meningeal sequelae24.
There are also two studies which did not reach 
conclusions as to the causes of the hearing loss. In the 
first one, with nine HIV-positive men, between 25 and 
42 years of age, there were five with hearing loss25. 
The second is a case study with a 36-year-old man 
with unilateral progressive hearing loss, high ipsilateral 
tinnitus, sudden hearing loss followed by ipsilateral 
paralysis. In an MRI they suspected of a vestibular 
schwannoma; however, when they ordered the anti-
-HIV they found the patient was serum-positive. The 
authors recommended a thorough exam to investigate 
the cause of the hearing loss26.
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Knowing that, every day, HIV/AIDS kills 6,000 
people and infects some 8,20035 more and infection by 
opportunistic agents is a constant concern of patients 
with HIV, we stress the need to pay special attention 
to the early diagnosis and prevention of hearing loss 
disorders.
CONCLUSIONS
We conclude that there is still no consensus in 
the studies we analyzed, concerning a determining 
factor for hearing disorders and hearing loss in persons 
who live with HIV/AIDS, and these changes are rela-
ted to multiple factors. Among them we stress a high 
viral load, direct virus action on the cochleovestibular 
system, the use of TARV and opportunistic infections 
- having cytomegalovirus, meningitis, otosyphilis and 
treatments, the ones most correlated to the hearing 
disorder and ototoxicity.
Therefore, it was not possible to find a direct 
association between the ARV treatment and the hea-
ring loss. Notwithstanding, we found hearing disorders 
in the population investigated, and their associations 
and causes are still not clear enough and concluding, 
which fosters the need for studies investigating the 
hearing loss in this population in a more in-depth 
manner.
To those adult and children with HIV/AIDS, we 
recommend hearing monitoring in Hearing Reference 
Centers, minimizing the effects from hearing-loss-cau-
sing factors, thus reducing the psychosocial impact 
and providing a better quality of life to these people.
Therefore, we require new studies, going more 
in-depth concerning the hearing disorders of patients 
with HIV/AIDS, which may become references for 
the initiatives of training and bringing awareness to 
healthcare professionals as to its problems and control.
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